Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients
Lauren G. Aoude, Vanessa Bonazzi, Sandra Brosda, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Human RecQ Helicases in DNA Double-Strand Break Repair
Huiming Lu, Anthony J. Davis
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 55
Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
Lauren G. Aoude, Bernadette Z.Y. Wong, Vanessa Bonazzi, et al.
Molecular Cancer Research (2021) Vol. 19, Iss. 6, pp. 950-956
Open Access | Times Cited: 30
RNAseq-Based Machine Learning Models for Prognostication of Multiple Myeloma
Krish Shah -, Kaina A. Millan, Anna Puła, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Introduction: navigating the landscape of cancer biomarkers
J. N. Baruah, Sthiti Porna Dutta, Partha Pratim Das, et al.
Elsevier eBooks (2025), pp. 1-41
Closed Access
Current state of knowledge of human DNA polymerase eta protein structure and disease-causing mutations
Bruno César Feltes, Carlos Frederico Martins Menck
Mutation Research/Reviews in Mutation Research (2022) Vol. 790, pp. 108436-108436
Open Access | Times Cited: 10
A genome-wide association study of germline variation and melanoma prognosis
Vylyny Chat, Sasha Dagayev, Una Moran, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 4
Blood-based molecular and cellular biomarkers of early response to neoadjuvant PD-1 blockade in patients with non-small cell lung cancer
Xi Zhang, Rui Chen, Zirong Huo, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
XPC multifaceted roles beyond DNA damage repair: p53-dependent and p53-independent functions of XPC in cell fate decisions
Abir Zebian, Maya El-Dor, Abdullah Shaito, et al.
Mutation Research/Reviews in Mutation Research (2021) Vol. 789, pp. 108400-108400
Open Access | Times Cited: 7
Recurrent germline variant in ATM associated with familial myeloproliferative neoplasms
Evan M. Braunstein, Eddie L. Imada, Sergiu Pașca, et al.
Leukemia (2022) Vol. 37, Iss. 3, pp. 627-635
Closed Access | Times Cited: 5
Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis
Arrate Sevilla, Ana Sánchez-Díez, Sofía Cobo, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2004-2004
Open Access | Times Cited: 4
Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report
Ana Mordoh, Juan Carlos Triviño Pardo, Ibel Carri, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting
Irene Vanni, Lorenza Pastorino, Enrica T. Tanda, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4302-4302
Open Access | Times Cited: 2
Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients
Elisabetta Vergani, Simona Frigerio, Matteo Dugo, et al.
Genes (2021) Vol. 12, Iss. 9, pp. 1440-1440
Open Access | Times Cited: 5
RNA modification writers influence tumor microenvironment in gastric cancer and prospects of targeted drug therapy
Peng Song, Sheng Zhou, Xiaoyang Qi, et al.
Journal of Bioinformatics and Computational Biology (2022) Vol. 20, Iss. 02
Open Access | Times Cited: 3
Clinical and Immunologic Features of Germline Pathogenic Variant–Positive Patients with Melanoma
Alan Shen, Michelle Arbesman, Roshan Lodha, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 3, pp. 564-574
Closed Access | Times Cited: 1
Melanoma Clinicopathology
Jean‐Jacques Grob, C. Gaudy‐Marqueste
(2024), pp. 1-31
Closed Access
Identification of New m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Landscape that Predict Clinical Outcomes for Papillary Renal Cell Carcinoma Patients
Bin Zheng, Fajuan Cheng, Zhigang Yao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 2
Data from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
Lauren G. Aoude, Bernadette Z.Y. Wong, Vanessa Bonazzi, et al.
(2023)
Open Access
Page 1

Scroll to top